UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000031646
Receipt number R000036136
Scientific Title Evaluation of the efficacy and safety of 5mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in gynecologic cancer patients: a multicenter phase 2 study.
Date of disclosure of the study information 2018/04/05
Last modified on 2020/01/16 17:00:35

No. Disposal Last modified on Item of update
1 Insert 2018/03/09 10:02:07
2 Update 2018/03/15 09:46:14 Key secondary outcomes
3 Update 2018/04/05 13:34:53 Recruitment status
Anticipated trial start date
4 Update 2018/04/05 13:37:46 Research ethics review
Date of disclosure of the study information
5 Update 2019/08/19 09:52:36 Recruitment status
Date of IRB
Last follow-up date
6 Update 2020/01/16 16:58:07 Recruitment status
7 Update 2020/01/16 16:58:35 Publication of results
Number of participants that the trial has enrolled
8 Update 2020/01/16 17:00:35 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email